Solius
Bainbridge Island, US · Delaware corporation · 1 known investors
Solius makes an FDA-cleared, over-the-counter UVB light therapy device that analyzes a user's skin tone to deliver a personalized dose of UVB light for vitamin D production and other systemic health benefits. The device pairs with a mobile app for skin analysis and dosing, positioning itself as a controlled alternative to natural sunlight, tanning beds, and traditional phototherapy.
Founders & leadership
CK
Chris KipleinExecutive
RW
Robert WiseExecutive
DG
David GoodExecutive
AM
Alexander MoffatExecutive
RH
Rick HennesseyExecutive
DG
Dave GoodChief Special Projects Officer
Board
CA
Christopher AckerleyBoard director
BP
Brett ParentBoard director
SH
Scott HirschBoard director
RW
Rick WhiteBoard director
EH
Elwood HowseBoard director
Investors · 1
Funding
SEC filings, press & company announcements$53.9M disclosed across 5 rounds · 2014–2026
- $23MraisedJun 2026Source ↗
▶$3.5MraisedMay 2026 · 2 investors · Other Health CareRule 506(b)
▶$3.5MraisedMay 2026 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Chris KipleExecutive Officer, Director
- Robert WiseExecutive Officer
- Brett ParentDirector
- Scott HirschDirector
- David GoodExecutive Officer
- Christopher AckerleyDirector
- Rick WhiteDirector
- Offering amount
- $17.9M
- Amount sold
- $3.5M
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$23.5MraisedMay 2026 · 11 investors · Other Health CareRule 506(b)
▶$23.5MraisedMay 2026 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Rick WhiteDirector
- Brett ParentDirector
- Scott HirschDirector
- Robert WiseExecutive Officer
- David GoodExecutive Officer
- Chris KipleExecutive Officer, Director
- Christopher AckerleyDirector
- Offering amount
- $23.5M
- Amount sold
- $23.5M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$788.2KraisedOct 2018 · 4 investors · Other TechnologyRule 506(b)
▶$788.2KraisedOct 2018 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Brett R ParentDirector
- Elwood Denison HowseDirector
- Rick J. HenneseyExecutive Officer, Director
- William Alexander MoffatDirector
- Bob WiseExecutive Officer
- Christopher H AckerleyDirector
- Offering amount
- $12.8M
- Amount sold
- $788.2K
- Sales commissions
- $5K
- Placement agents
- Capital Suisse LLC
- First sale
- Oct 2018
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$3.1MraisedDec 2015 · 23 investors · Other TechnologyRule 506(b)
▶$3.1MraisedDec 2015 · 23 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Alexander MoffatExecutive Officer, Director, Promoter
- Elwood HowseDirector
- Rick HennesseyExecutive Officer, Director, Promoter
- Offering amount
- $7M
- Amount sold
- $3.1M
- Minimum investment
- $10K
- First sale
- Nov 2014
- Incorporated
- Corporation, Washington, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Cancerresearchuk27 shared keywordsCancer Research UK funds research across discovery, detection, prevention and treatment of cancer to improve patient outcomes and extend survival. It operates as a research funder and scientific organization serving academic and clinical researchers.
Ro25 shared keywordsRo is an online healthcare platform that connects patients with licensed providers and delivers prescription treatments, including GLP-1 medications for weight loss, ED treatments, and other health goals. The direct-to-consumer telehealth service is fully online and serves individual patients in the United States.
Uclahealth22 shared keywordsUCLA Health is an academic health system providing primary, immediate, and specialty medical care including cancer, neuroscience, transplant, orthopedics, cardiovascular, and children's care. It operates hospitals and clinics and trains medical students, with a network of locations in the Los Angeles area.
Companies competing with Solius for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Selling sunshine from Seattle: Solius raises $23M to launch new at-home light-therapy device – GeekWiregeekwire.com · Jun 2026Frequently asked questions
- What does Solius do?
- Solius makes an FDA-cleared, over-the-counter UVB light therapy device that analyzes a user's skin tone to deliver a personalized dose of UVB light for vitamin D production and other systemic health benefits. The device pairs with a mobile app for skin analysis and dosing, positioning itself as a controlled alternative to natural sunlight, tanning beds, and traditional phototherapy.
- Who are Solius's investors?
- Solius's investors include Lauder Partners.
- How much funding has Solius raised?
- Solius has disclosed $53.9M raised across 5 rounds.
- Where is Solius headquartered?
- Solius is headquartered in Bainbridge Island, US.